Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs) cause atherosclerotic cardiovascular disease (ASCVD). We assessed whether the association between LDL and ASCVD fulfils the criteria for causality by evaluating the totality of evidence from genetic studies, prospecti...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European heart journal Ročník 38; číslo 32; s. 2459
Hlavní autoři:	Ference, Brian A, Ginsberg, Henry N, Graham, Ian, Ray, Kausik K, Packard, Chris J, Bruckert, Eric, Hegele, Robert A, Krauss, Ronald M, Raal, Frederick J, Schunkert, Heribert, Watts, Gerald F, Borén, Jan, Fazio, Sergio, Horton, Jay D, Masana, Luis, Nicholls, Stephen J, Nordestgaard, Børge G, van de Sluis, Bart, Taskinen, Marja-Riitta, Tokgözoglu, Lale, Landmesser, Ulf, Laufs, Ulrich, Wiklund, Olov, Stock, Jane K, Chapman, M John, Catapano, Alberico L
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 21.08.2017
Témata:	Anticholesteremic Agents - therapeutic use Atherosclerosis - etiology Atherosclerosis - prevention & control Cholesterol, HDL - metabolism Cholesterol, LDL - metabolism Consensus Epidemiologic Methods Ezetimibe - therapeutic use Genetic Predisposition to Disease - genetics Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hyperlipidemias - prevention & control Lipoproteins, LDL - physiology PCSK9 Inhibitors Low-density lipoprotein Recommendations Atherosclerosis Ezetimibe Clinical trials Cardiovascular disease PCSK9 Mendelian randomization Statin Causality
ISSN:	1522-9645, 1522-9645
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!